CMH :: Clinical and Molecular Hepatology

REVIEW Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Gadoxetic acid, a hepatocyte-specific magnetic resonance imaging (MRI) contrast agent, has emerged as an important tool for hepatocellular carcinoma (HCC) diagnosis. Gadoxetic acid-enhanced MRI is useful for the evaluation of earlystage HCC, diagnosis of HCC precursor lesions, a...

REVIEW Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
The goal of this review is to present the similarities and differences among the latest guidelines for noninvasive diagnosis of hepatocellular carcinoma (HCC) of American Association for the Study of Liver Disease (AASLD), European Association for the Study of the Liver (EASL), ...

REVIEW Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Sarcopenia (loss of muscle mass and/or strength) frequently complicates liver cirrhosis and adversely affects the quality of life; cirrhosis related liver decompensation and significantly decreases wait-list and post-liver transplantation survival. The main therapeutic strategie...

Current Issue

Volume 25(3); Sep 2019

Volume 25(2); June 2019

Volume 25(1); March 2019

Volume 24(4); December 2018

Volume 24(3); September 2018

Most-cited are based on citations from 2017 ~ 2019.

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol.2017;23(1):1-12. Published online March 9, 2017
DOI: https://doi.org/10.3350/cmh.2016.0109

Cited By 43

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol.2018;24(1):1-9. Published online December 18, 2017
DOI: https://doi.org/10.3350/cmh.2017.0112

Cited By 25

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis

Gaeun Kim, Moon Young Kim, Soon Koo Baik

Clin Mol Hepatol.2017;23(1):34-41. Published online March 7, 2017
DOI: https://doi.org/10.3350/cmh.2016.0059

Cited By 22

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol.2017;23(3):205-211. Published online September 19, 2017
DOI: https://doi.org/10.3350/cmh.2017.0104

Cited By 22

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol.2017;23(1):13-21. Published online March 14, 2017
DOI: https://doi.org/10.3350/cmh.2016.0110

Cited By 16

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system

Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin

Clin Mol Hepatol.2017;23(4):280-289. Published online September 15, 2017
DOI: https://doi.org/10.3350/cmh.2017.0037

Cited By 14

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol.2017;23(2):109-114. Published online May 10, 2017
DOI: https://doi.org/10.3350/cmh.2017.0004

Cited By 12

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

Dong Ho Lee

Clin Mol Hepatol.2017;23(4):290-301. Published online October 10, 2017
DOI: https://doi.org/10.3350/cmh.2017.0042

Cited By 12

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol.2018;24(2):100-107. Published online December 22, 2017
DOI: https://doi.org/10.3350/cmh.2017.0067

Cited By 12

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study

Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae

Clin Mol Hepatol.2017;23(1):51-56. Published online March 16, 2017
DOI: https://doi.org/10.3350/cmh.2016.0053

Cited By 11

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol.2017;23(4):265-272. Published online November 8, 2017
DOI: https://doi.org/10.3350/cmh.2017.0111

Cited By 11

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol.2017;23(4):302-307. Published online December 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0078

Cited By 11

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol.2017;23(2):128-137. Published online May 10, 2017
DOI: https://doi.org/10.3350/cmh.2016.0071

Cited By 10

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol.2017;23(2):103-108. Published online May 10, 2017
DOI: https://doi.org/10.3350/cmh.2017.0103

Cited By 9

Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function

Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique

Clin Mol Hepatol.2017;23(4):316-322. Published online August 22, 2017
DOI: https://doi.org/10.3350/cmh.2016.0087

Cited By 9

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol.2018;24(3):230-277. Published online July 9, 2018
DOI: https://doi.org/10.3350/cmh.2018.1005

Cited By 9

Epithelioid angiomyolipoma of the liver: a case report

Soo Yeon Lee, Baek-hui Kim

Clin Mol Hepatol.2017;23(1):91-94. Published online March 17, 2017
DOI: https://doi.org/10.3350/cmh.2017.0011

Cited By 8

Treatment options after sorafenib failure in patients with hepatocellular carcinoma

Imane El Dika, Ghassan K. Abou-Alfa

Clin Mol Hepatol.2017;23(4):273-279. Published online November 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0108

Cited By 7

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis

Dae Hoe Gu, Moon Young Kim, Yeon Seok Seo, Sang Gyune Kim, Han Ah Lee, Tae Hyung Kim, Young Kul Jung, Altay Kandemir, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol.2018;24(3):319-330. Published online April 30, 2018
DOI: https://doi.org/10.3350/cmh.2017.0077

Cited By 7

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

Saba Sayari, Hassan Neishaboori, Maryam Jameshorani

Clin Mol Hepatol.2018;24(3):331-338. Published online June 12, 2018
DOI: https://doi.org/10.3350/cmh.2018.0006

Cited By 7